BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 18559768)

  • 1. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
    Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
    J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
    Ho JC; Ng PL; Tan SH; Giam YC
    Pediatr Dermatol; 2007; 24(5):E40-3. PubMed ID: 17958778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels.
    Walsh SN; Kerchner K; Sangüeza OP
    Arch Dermatol; 2009 May; 145(5):603-4. PubMed ID: 19451516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug induced linear IgA bullous dermatosis].
    Montagnac R; Reguiaï Z; Méhaut S; Bressieux JM; Schillinger F
    Nephrologie; 2003; 24(6):287-92. PubMed ID: 14584295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
    Plunkett RW; Chiarello SE; Beutner EH
    J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
    Jones DH; Todd M; Craig TJ
    J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A successful challenge in a patient with vancomycin-induced linear IgA dermatosis.
    Joshi S; Scott G; Looney RJ
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):101-3. PubMed ID: 15281479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
    Kovacic D; Fox M; Reichenberg J
    J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
    Jawitz RS; Krach K; Schapiro B
    Arch Dermatol; 2011 Dec; 147(12):1443, 1448. PubMed ID: 22184772
    [No Abstract]   [Full Text] [Related]  

  • 13. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient.
    Eisendle K; Bonatti H; Sepp N; Höpfl R
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):996-7. PubMed ID: 17659024
    [No Abstract]   [Full Text] [Related]  

  • 15. Depot sulfonamid associated linear IgA bullous dermatosis with erythema multiforme-like clinical features.
    Tonev S; Vasileva S; Kadurina M
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):165-8. PubMed ID: 9784046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Coelho S; Tellechea O; Reis JP; Mariano A; Figueiredo A
    Int J Dermatol; 2006 Aug; 45(8):995-6. PubMed ID: 16911399
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-associated linear IgA disease mimicking toxic epidermal necrolysis.
    Khan I; Hughes R; Curran S; Marren P
    Clin Exp Dermatol; 2009 Aug; 34(6):715-7. PubMed ID: 19077099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linear IgA dermatosis and pulmonary tuberculosis in an adult. Apropos of a case].
    Pujol C; Alegre VA; Guillen C; Navarro R; Raez R; Lidon J
    Med Cutan Ibero Lat Am; 1988; 16(1):39-42. PubMed ID: 2967408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection.
    Ahkami R; Thomas I
    Cutis; 2001 May; 67(5):423-6. PubMed ID: 11381861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.